Why Mira Pharmaceuticals Stock Is Moving Higher Monday
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) shares are trading higher after the company said testing has confirmed its preliminary beliefs regarding a new potential treatment for neurological and
Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Falls In July
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 200 points on Monday.Following the market opening Monday, the Dow traded up 0.62% to 40,249.41 while the NASDAQ
ASLAN Pharmaceuticals ASLN Delist; MIRA Pharmaceuticals MIRA Preclinical Data
Express News | MIRA Pharmaceuticals Shares Are Trading Higher After the Company Said Testing Confirmed MIRA's Preliminary Beliefs Regarding Potential Treatment for Neurological and Neuropsychiatric Disorders
Mira Pharmaceuticals Announces Promising Results for MIRA-55 in Multiple Preclinical Tests Compared to THC
MIRA Pharmaceuticals, Inc. (Nasdaq:MIRA) ("MIRA" or the "Company"), a pre-clinical-stage pharmaceutical development company, today announced promising new findings from recent preclinical studies of its novel oral pharmaceutical marijuana analog, MIRA-55, which is being studied as a potential treatment for anxiety and cognitive decline.
Express News | MIRA Pharmaceuticals Announces Preclinical Results Showing Ketamir-2 Does Not Induce Hyper-Locomotor Activity
Express News | Mira Pharmaceuticals: Ketamir-2 Shows Promising Safety Profile in Comparison to Traditional Ketamine in Preclinical Testing
Express News | Mira Pharmaceuticals Announces Positive Preclinical Study Results for Its Novel Oral Ketamine Analog, Ketamir-2, Paving Way for Ind Submission Later This Year
Mira Pharmaceuticals Announces Positive Preclinical Study Results For Its Novel Oral Ketamine Analog, Ketamir-2, Paving the Way for IND Submission Later This Year
MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) ("MIRA" or the "Company"), a pre-clinical-stage pharmaceutical company focused on the treatment of...
12 Health Care Stocks Moving In Thursday's Intraday Session
GainersCue Health (NASDAQ:HLTH) shares rose 70.1% to $0.09 during Thursday's regular session. The market value of their outstanding shares is at $14.8 million. OneMedNet (NASDAQ:ONMD) shares increased
Sector Update: Health Care Stocks Retreat Wednesday Afternoon
Health care stocks were slipping Wednesday afternoon, with the NYSE Health Care Index falling 0.8% and the Health Care Select Sector SPDR Fund (XLV) down 0.9%. The iShares Biotechnology ETF (IBB) drop
MIRA Pharmaceuticals Enhances CEO's Compensation Package
Express News | Mira Pharmaceuticals Inc: Dea Rules Mira-55, a Novel Oral Pharmaceutical Marijuana Analog, Is Not Classified as a Controlled Substance
MIRA Pharmaceuticals(MIRA.US) Officer Buys US$8,176 in Common Stock
$MIRA Pharmaceuticals(MIRA.US)$ Officer Aminov Erez purchased 8,700 shares of common stock on May 21, 2024 at an average price of $0.94 for a total value of $8,176.Source: Announcement What is stateme
Express News | Watching MIRA Pharmaceuticals; Zacks Small-Cap Research Says Co Is Creating A THC Analog That Has The Same Benefits As THC Without The Negative Side Effects. We Value MIRA At $16.50 Using Discontinued Cash Flow Analysts And A 20% Discount Rate
Express News | Mira Pharmaceuticals in Discussions With Memorial Sloan Kettering to Collaborate on Preclinical Cancer Pain Model Utilizing the Company's Novel Oral Ketamine Analog
Dow Falls Over 150 Points; Sohu Posts Q1 Loss
U.S. stocks traded mixed toward the end of trading, with the Dow Jones index falling more than 150 points on Monday.The Dow traded down 0.43% to 39,831.18 while the NASDAQ rose 0.53% to 16,775.01. The
Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Virios Therapeutics, Inc. (NASDAQ:VIRI) fell sharply during Monday's session after the company priced a $1.7 million public offering of 8.5 million shares of common stock at $0.20 per share.
Express News | Mira Pharmaceuticals Shares Are Trading Higher After the Company Said It Has Advanced New Preclinical Studies Using Ketamir-2 Towards Clinical Development
Express News | Mira Pharmaceuticals Advances Preclinical Studies Using Ketamir-2 Towards Clinical Development
No Data